Algernon Pharmaceuticals Inc (AGNPF)

[Lowersioux5]

Yes I'm aware of this interview and what what was said.

We both agree on everything except whether it moves directly into Phase3. It's a matter of semantics, in my opinion.

While there will be delay to the start, based off Phase2 data of which will be calculated into Phase3 enrollment, it's only to assess the data from Phase2.

There will be no "application/approval process". It is already authorized.

As he states at 18:30, it's a Phase 2b/3 study.

As for the Summer of '21 projection..

I will be (nearly) long gone by then.

This has always been an, as you stated, "Option 3" best-case scenario for investor's.

I've been invested for nearly 4yrs. After contemplating total sell-off after the reverse-split, I became interested in the "repurposed drugs" idea (thanks to the great DD offered here by the Band..lol).

COVID-19 came and the connection to what the company was already investigating, and, it should be noted again.. unlike most pursuing a treatment/therapeutic, COVID-19 came to Algernon.

So I increased my position.

I will always stick around with a few tickets to see where my original investment goes with IPF/Chronic Cough.. and the other 3 in the pipeline. But the COVID-19 angle is coming to a Day of Reckoning, and soon.

Good luck Algernaut's... commencing Countdown.

LS5